MunaQayedMD
Pediatric Hematology & Oncology • Atlanta, GAAssistant Professor, Pediatrics, Emory University School of Medicine
Dr. Qayed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Emory UniversityMSc, Clinical Research, 2010
Children's Hospital of MichiganResidency, Pediatrics, 2004 - 2007
University of Jordan Faculty of MedicineClass of 2002
Certifications & Licensure
GA State Medical License 2007 - 2024
MI State Medical License 2004 - 2007- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors Start of enrollment: 2011 Apr 01
- Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2012 Dec 10
- Abatacept as GVHD Prophylaxis Phase 2 Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSecondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.Michael D Keller, Stefan A Schattgen, Shanmuganathan Chandrakasan, E Kaitlynn Allen, Mariah A Jensen-Wachspress
Nature Communications. 2024-03-29 - 59 citationsAn early-biomarker algorithm predicts lethal graft-versus-host disease and survival.Matthew J Hartwell, Umut Özbek, Ernst Holler, Anne S Renteria, Hannah Major-Monfried
JCI Insight. 2017-02-09 - 13 citationsAssessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.Aaron Etra, Stephanie Gergoudis, George Morales, Nikolaos Spyrou, Jay Shah
Blood Advances. 2022-06-28
Journal Articles
- Genetic Mechanisms of Target Antigen Loss in CAR19 Therapy of Acute Lymphoblastic LeukemiaJohn E Levine, Muna Qayed, Stephan A Grupp, Eneida R Nemecek, Stella M Davies, Michael R Verneris, Michael Boyer, Jeffrey A Engelman, Nature
- Indoles Derived from Intestinal Microbiota Act via Type I Interferon Signaling to Limit Graft-Versus-Host-DiseaseEdmund K Waller, Zachariah DeFilipp, Muna Qayed, Akshay Sharma, Blood
Abstracts/Posters
- Transcriptomic Analysis of CD4+ T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28...Muna Qayed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous...Muna Qayed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseMuna Qayed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Peach Bowl Inc. Funds 5 New Research Projects at Children’s Healthcare of AtlantaNovember 2nd, 2022
- Woman Wants to Become a Nurse After Battling Leukemia as Teen, Overcoming OddsJune 4th, 2021
Arthritis Drug Cuts GVHD Risk in Stem Cell TransplantsJanuary 25th, 2021- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
